Improving Global Outcomes (KDIGO) group has updated chronic kidney disease treatment guidelines to help slow disease progression in adults. A JAMA article published Wednesday summarized the revised ...

Most individuals with chronic kidney disease (CKD) are unaware of their disease, according to a KDIGO controversies conference on CKD prevention.

Despite its profound impact on patient health, anemia of chronic kidney disease (CKD) remains underdiagnosed and undertreated.

The update amends the 2009 KDIGO Clinical Practice Guideline and presents revised positions on current standards of care for the treatment of secondary hyperparathyroidism (SHPT) in patients with ...

The expanded indication for BP-lowering treatment by the 2021 Kidney Disease: Improving Global Outcomes guideline affects more than 10% of patients with chronic kidney disease, who are at higher ...

Similarly, 17.8% of those with stage G1-A2 CKD, 44% of those with stage G2-A2 and 61.3% of those with stage G3a-A1 CKD patients progressed to a higher KDIGO risk category.

Gout management u2028in patients with CKD Each month, Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in ...

Most patients with undiagnosed CKD had stage 3 (82%). Compared with CKD patients with a diagnosis, those who went undiagnosed were more often female (63% vs 45%) and white (78% vs 72%).

The impact of chronic kidney disease (CKD) on patients and the health care system in the United States is substantial and expected to increase with the expanding obesity-driven diabetes epidemic.1 ...